Who is funding R&D for emerging infectious diseases? Dr Paul Barnsley, Policy Cures Research

Contain This: The Latest in Global Health Security

Indo-Pacific Centre for Health Security: Department of Foreign Affairs and Trade and Indo-Pacific Centre for Health Security: Department of Foreign Affairs에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Indo-Pacific Centre for Health Security: Department of Foreign Affairs and Trade and Indo-Pacific Centre for Health Security: Department of Foreign Affairs 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

2y ago 28:09

MP3•에피소드 홈

Last month at the Global Health Security Conference in Singapore, Policy Cures Research launched their second edition of the Landscape of Emerging Infectious Disease Research and Development funding report, supported by the Australian Government.

Our guest this week is Dr Paul Barnsley, Senior Analyst at Policy Cures Research, and the lead author of the report, who joins us to talk about its key findings.

We discuss how R&D funding for Ebola ultimately led to success in creating a stable of products that limits its risk of its pandemic potential. Plus, how the unprecedented R&D response to the Covid-19 pandemic is reshaped the funding landscape for emerging infectious disease R&D into the future.

Dr Barnsley also speaks about the promising new entrants in EID R&D funding from low to middle income countries, given that they are often the countries that epidemic disease does most harm.

We hope you join the conversation at @CentreHealthSec and follow Policy Cures Research at @PCuresResearch.

To access Policy Cures Research reports, visit https://www.policycuresresearch.org/analysis/
To access G-FINDER data, visit https://gfinderdata.policycuresresearch.org/

76 에피소드

#Science #News #Government #Health and Well-Being #Health Security #Research #Innovation #Development #Covid #World #Global #Policy